MENTA CAPITAL LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
MENTA CAPITAL LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$259,000
-5.5%
7,8240.0%0.11%
-8.3%
Q1 2019$274,000
+5.4%
7,8240.0%0.12%
+25.0%
Q4 2018$260,000
-31.8%
7,824
+3.5%
0.10%
-27.8%
Q3 2018$381,000
-17.7%
7,559
-2.4%
0.13%
+23.1%
Q2 2018$463,000
-4.1%
7,743
-26.6%
0.11%
+4.9%
Q1 2018$483,000
+14.2%
10,543
-0.7%
0.10%
+25.6%
Q4 2017$423,000
+0.2%
10,615
+0.7%
0.08%
+32.3%
Q3 2017$422,000
-20.1%
10,543
-13.9%
0.06%
-1.6%
Q2 2017$528,000
-81.4%
12,243
-86.5%
0.06%
-77.3%
Q1 2017$2,840,000
-25.4%
90,735
-39.8%
0.28%
-12.6%
Q4 2016$3,806,000
-22.3%
150,716
-23.9%
0.32%
-31.9%
Q3 2016$4,899,000
+89.2%
198,109
+55.9%
0.47%
+31.2%
Q2 2016$2,589,000
+263.6%
127,080
+172.3%
0.36%
+267.0%
Q1 2016$712,000
-19.5%
46,673
-29.1%
0.10%
-13.4%
Q4 2015$885,000
-10.3%
65,865
-6.4%
0.11%
-28.2%
Q3 2015$987,000
-56.8%
70,384
-47.7%
0.16%
-58.2%
Q2 2015$2,284,000
+12.1%
134,529
-20.2%
0.37%
+41.8%
Q1 2015$2,038,000
+163.0%
168,597
+80.5%
0.26%
+139.1%
Q4 2014$775,00093,4010.11%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders